Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Novel composed galactosylated nanodevices containing a ribavirin prodrug as hepatic cell-targeted carriers for HCV treatment.

Craparo EF, Teresi G, Licciardi M, Bondí ML, Cavallaro G.

J Biomed Nanotechnol. 2013 Jun;9(6):1107-22.

PMID:
23858977
[PubMed - indexed for MEDLINE]
2.

Galactosylated micelles for a ribavirin prodrug targeting to hepatocytes.

Craparo EF, Triolo D, Pitarresi G, Giammona G, Cavallaro G.

Biomacromolecules. 2013 Jun 10;14(6):1838-49. doi: 10.1021/bm4002409. Epub 2013 May 10.

PMID:
23621358
[PubMed - indexed for MEDLINE]
3.

Galactosylated polymeric carriers for liver targeting of sorafenib.

Craparo EF, Sardo C, Serio R, Zizzo MG, Bondì ML, Giammona G, Cavallaro G.

Int J Pharm. 2014 May 15;466(1-2):172-80. doi: 10.1016/j.ijpharm.2014.02.047. Epub 2014 Mar 4.

PMID:
24607205
[PubMed - in process]
4.

Galactosylated α,β-poly[(2-hydroxyethyl)-L-aspartamide]-bound doxorubicin: improved antitumor activity against hepatocellular carcinoma with reduced hepatotoxicity.

Cheng X, Gao F, Xiang J, Jiang X, Chen J, Zhang J.

Anticancer Drugs. 2011 Feb;22(2):136-47. doi: 10.1097/CAD.0b013e3283406e85.

PMID:
20966743
[PubMed - indexed for MEDLINE]
5.
6.

Synthesis and characterization of a hemoglobin-ribavirin conjugate for targeted drug delivery.

Brookes S, Biessels P, Ng NF, Woods C, Bell DN, Adamson G.

Bioconjug Chem. 2006 Mar-Apr;17(2):530-7.

PMID:
16536487
[PubMed - indexed for MEDLINE]
7.

Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin.

Jain NK, Jain SK.

AAPS PharmSciTech. 2010 Jun;11(2):686-97. doi: 10.1208/s12249-010-9422-z. Epub 2010 Apr 23.

PMID:
20414758
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Galactosylated poly(ethylene glycol)-b-poly (l-lactide-co-β-malic acid) block copolymer micelles for targeted drug delivery: preparation and in vitro characterization.

Suo A, Qian J, Yao Y, Zhang W.

Int J Nanomedicine. 2010 Nov 23;5:1029-38. doi: 10.2147/IJN.S14280.

PMID:
21170351
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes.

Zhang XQ, Wang XL, Zhang PC, Liu ZL, Zhuo RX, Mao HQ, Leong KW.

J Control Release. 2005 Feb 16;102(3):749-63.

PMID:
15681095
[PubMed - indexed for MEDLINE]
10.

PHEA-graft-polybutylmethacrylate copolymer microparticles for delivery of hydrophobic drugs.

Licciardi M, Di Stefano M, Craparo EF, Amato G, Fontana G, Cavallaro G, Giammona G.

Int J Pharm. 2012 Aug 20;433(1-2):16-24. doi: 10.1016/j.ijpharm.2012.04.052. Epub 2012 Apr 27.

PMID:
22575755
[PubMed - indexed for MEDLINE]
11.

Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8.

Tokumoto Y, Hiasa Y, Uesugi K, Watanabe T, Mashiba T, Abe M, Kumagi T, Ikeda Y, Matsuura B, Onji M.

J Infect Dis. 2012 Apr 1;205(7):1121-30. doi: 10.1093/infdis/jis025. Epub 2012 Feb 21.

PMID:
22357660
[PubMed - indexed for MEDLINE]
Free Article
12.

Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C.

Ross AS, Bhan AK, Pascual M, Thiim M, Benedict Cosimi A, Chung RT.

Clin Transplant. 2004 Apr;18(2):166-73.

PMID:
15016131
[PubMed - indexed for MEDLINE]
13.

Nanoaggregates based on new poly-hydroxyethyl-aspartamide copolymers for oral insulin absorption.

Licciardi M, Pitarresi G, Cavallaro G, Giammona G.

Mol Pharm. 2013 May 6;10(5):1644-54. doi: 10.1021/mp300226d. Epub 2013 Mar 22.

PMID:
23331253
[PubMed - indexed for MEDLINE]
14.

Narrow therapeutic window of ribavirin as an inhibitor of nitric oxide synthesis is broadened by macromolecular prodrugs.

Wohl BM, Smith AA, Kryger MB, Zelikin AN.

Biomacromolecules. 2013 Nov 11;14(11):3916-26. doi: 10.1021/bm401048s. Epub 2013 Oct 24.

PMID:
24156371
[PubMed - indexed for MEDLINE]
15.

Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin.

Zhou N, Zan X, Wang Z, Wu H, Yin D, Liao C, Wan Y.

Carbohydr Polym. 2013 Apr 15;94(1):420-9. doi: 10.1016/j.carbpol.2013.01.014. Epub 2013 Jan 16.

PMID:
23544558
[PubMed - indexed for MEDLINE]
16.

Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients.

Crespo M, Pou L, Esteban JI, Falcó V, Ribera E, Lopez R, Sauleda S, Curran A, Villar del Saz S, Feijoo M, Ocaña I, Pahissa A.

Antivir Ther. 2007;12(8):1217-23.

PMID:
18240861
[PubMed - indexed for MEDLINE]
17.

Biocompatible polymeric micelles with polysorbate 80 for use in brain targeting.

Craparo EF, Ognibene MC, Casaletto MP, Pitarresi G, Teresi G, Giammona G.

Nanotechnology. 2008 Dec 3;19(48):485603. doi: 10.1088/0957-4484/19/48/485603. Epub 2008 Nov 12.

PMID:
21836304
[PubMed]
18.

Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trial.

Rodriguez-Torres M, Slim J, Bhatti L, Sterling R, Sulkowski M, Hassanein T, Serrão R, Sola R, Bertasso A, Passe And S, Stancic S.

HIV Clin Trials. 2012 May-Jun;13(3):142-52. doi: 10.1310/hct1303-142.

PMID:
22592094
[PubMed - indexed for MEDLINE]
19.

Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.

Afdhal NH, Dieterich DT, Pockros PJ, Schiff ER, Shiffman ML, Sulkowski MS, Wright T, Younossi Z, Goon BL, Tang KL, Bowers PJ; Proactive Study Group.

Gastroenterology. 2004 May;126(5):1302-11.

PMID:
15131791
[PubMed - indexed for MEDLINE]
20.

Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery.

Wang Y, Jiang G, Qiu T, Ding F.

Drug Dev Ind Pharm. 2012 Sep;38(9):1039-46. doi: 10.3109/03639045.2011.637052. Epub 2011 Nov 29.

PMID:
22124381
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk